Migraine Clinical Trials in Amherst, New York

6 studies are recruiting for migraine in Amherst, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

   Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Dent Neurologic Institute - Amherst /ID# 231182, Amherst, New York

   Locations

   129 in total

   Run by

   AbbVie

   See if you can join NCT05125302 on ClinicalTrials.gov

2. Study of EVO756 in Adults With Migraine

   This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

   Stage

   Phase 2

   Ages

   18 to 64

   Site

   Clinosis - Dent Neurologic Instite, Amherst, New York

   Locations

   26 in total

   Run by

   Evommune, Inc.

   See if you can join NCT07616128 on ClinicalTrials.gov

3. Responding With Evidence and Access for Childhood Headaches

   This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for yo…

   Stage

   Not phased

   Ages

   10 to 17

   Site

   Dent Neurological Institute, Amherst, New York

   Locations

   15 in total

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT05889624 on ClinicalTrials.gov

4. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

   The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic migraine.

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Dent Neurosciences Research Center, Inc., Amherst, New York

   Locations

   93 in total

   Run by

   Pfizer

   See if you can join NCT05156398 on ClinicalTrials.gov

5. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

   This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Dent Neuro Institute, Buffalo, Amherst, New York

   Locations

   113 in total

   Run by

   Kallyope Inc.

   See if you can join NCT07645924 on ClinicalTrials.gov

6. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

   The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Dent Neurosciences Research Center Incorporated, Amherst, New York

   Locations

   70 in total

   Run by

   H. Lundbeck A/S

   See if you can join NCT05164172 on ClinicalTrials.gov